medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …
AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 3 months
Tempus buys Personalis genomics partner in $1.5B deal / 5 wks
AI face photos may predict cancer survival years earlier / 3 months
National study to use genetic testing to guide cancer survivor follow-up / 3 months
Supercentenarians show unusually vigilant cancer‑fighting immune cells / 7 days
Mass release of next‑generation tumor organoids accelerates research / 22 days
Some tumors kill neighboring healthy cells to fuel growth / 2 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.